Capps Green Zomaya Award 2018 Winners
Dr James Crawford
Dr Crawford received the Award for his work on drug discovery at both AstraZeneca UK and at Genentech USA. In particular for his contribution to the development of Cathepsin K inhibitors for the treatment of osteoarthritis, and of tyrosine kinase inhibitors currently in clinical trials for the treatment of rheumatoid arthritis, lupus and chronic spontaneous urticaria. Dr Crawford was presented with the Award on 26th April, 2018 and he delivered the 9th Memorial Lecture entitled 'Discovery of GDC-0853: a highly potent, selective, and non-covalent Btk inhibitor'.
Dr Richard Ward
Dr Ward received the Award for his work at AstraZeneca UK on small molecule drug discovery, and in particular for his contribution to the discovery and development of Tagrisso (Osimertinib), a new treatment for EGFR T790M-positive non-small cell lung cancer. Dr Ward was presented with the Award on 26th April, 2018 will present the 10th Memorial Lecture at the 30th Symposium on Medicinal Chemistry in April 2019.